< Back to previous page
Researcher
Thomas D'Hooghe
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Woman and Child (Division)
Member
From1 Apr 2013 → Today
Projects
1 - 10 of 21
- public financing of artificial reproductive technologies: ethical foundation, cost-effectiveness and allocation of resourcesFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Live fluorescence imaging system in environmental controlled stable conditionsFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- Redefining care processes for and with patients.From1 Oct 2015 → 10 Aug 2022Funding: FWO fellowships
- Mechanosensitive piezo1 as key player in the decidualization and implantation process?From5 Sep 2014 → 30 Sep 2021Funding: FWO fellowships, BOF - Doctoral projects
- miRNA as biomarker for endometriosisFrom1 Sep 2014 → 30 Sep 2020Funding: FWO fellowships
- The impact of psychological stress on decision making at fertiliteitsbe operations: in-depth interviews and set up an intervention.From1 Oct 2013 → 30 Sep 2014Funding: BOF - Other initiatives
- Characterization of Transient Receptor Potential (TRP) in human endometrium: in health and disease.From1 Oct 2013 → 30 Sep 2017Funding: BOF - Concerted Research Project from 1994
- Endometrial and embryonic genomics, searching for biomarkers in assisted reproductionFrom1 Jan 2013 → 31 Dec 2016Funding: Marie Curie - People
- Noninvasive diagnosis of endometriosis based on clinical risk factors and plasma proteomics/microRNA analysis.From1 Jan 2013 → 31 Dec 2016Funding: FWO research project
- Discovery, validation and improvement of non-invasive diagnostic models for endometriosisFrom1 Oct 2012 → 30 Sep 2018Funding: FWO fellowships
Publications
31 - 40 of 446
- Comparison between follitropin-delta and follitropin-alfa for ovarian stimulation in context of ART is only scientifically sound and clinically relevant if individualization of starting dose is allowed in both arms!(2022)
Authors: Thomas D'Hooghe
Pages: 623 - 624 - Ovarian stimulation strategies for intrauterine insemination in couples with unexplained infertility: a systematic review and individual participant data meta-analysis(2022)
Authors: Karen Peeraer, Thomas D'Hooghe
Pages: 733 - 746 - #ESHREjc report: diagnosing endometriosis loosens the Gordian knot of infertility treatment(2022)
Authors: Thomas D'Hooghe
Pages: 2219 - 2223 - The impact of force-degraded variants of recombinant human follicle stimulating hormone alfa (r-hFSH alfa) on in-vitro and in-vivo biological activity(2022)
Authors: Thomas D'Hooghe
Pages: I486 - I487 - Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions(2022)
Authors: Thomas D'Hooghe
- Great expectations of IVF patients: the role of gender, dispositional optimism and shared IVF prognoses(2022)
Authors: Karen Peeraer, Thomas D'Hooghe, Annouschka Laenen, Joris Vriens, Eline Dancet
Pages: 997 - 1006 - Down-regulation of long non-coding RNAs in reproductive aging and analysis of the lncRNA-miRNA-mRNA networks in human cumulus cells(2022)
Authors: Thomas D'Hooghe
Pages: 919 - 931 - Multiple live birth rate more than 60% after assisted reproductive technology treatment in patients with favorable prognosis: opportunity to address a reproductive public health and economic burden by improved adherence to guidelines combined with increased patient access to assisted reproductive technology care(2022)
Authors: Thomas D'Hooghe
Pages: 560 - 561 - Effect of Genetic Variants of Gonadotropins and Their Receptors on Ovarian Stimulation Outcomes: A Delphi Consensus(2022)
Authors: Thomas D'Hooghe
- A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study(2022)
Authors: Thomas D'Hooghe